Roche opens new CHF1.2-billion R&D centre in Basel
The pharmaceutical company Roche has opened a new research and development centre in Basel in northwest Switzerland. The firm has invested CHF1.2 billion ($1.3 billion) in the buildings designed by architects Herzog & de Meuron.
On Tuesday Roche announced the inauguration of its new “Pharma Research and Early Development Centre” at its global headquarters in Basel. The R&D centre comprises four research buildings at a cost of CHF1.2 billion – the group’s largest single investment in recent years. The facility will house 1,800 researchers.
+ Get the most important news from Switzerland in your inbox
Next to the two existing office towers in the centre of Basel – one is the tallest building in Switzerland at 205 metres – the four new buildings are hardly noticeable, despite being 114 metres high.
+ Roche gives details of CHF1.2bn Basel site investment
These new high-rise buildings are each divided into three-story units, which, according to Roche, creates smaller “research biotopes” of around 140 researchers from different disciplines each.
The aim of the new facility is to develop new “blockbuster” drugs, highly profitable products with sales of over CHF1 billion.
+ Roche inaugurates Switzerland’s tallest building
“In Basel, research is being carried out into therapies for serious diseases for which there is still no real solution on the market,” Roche manager Jürg Erismann told Swiss public radio, SRF. Research will focus on oncology, ophthalmology, neuroscience, infectious diseases and cardiovascular diseases.
Roche is a major employer and taxpayer in Basel – alongside Novartis – but also in other parts of Switzerland, totalling 15,000 staff.
+ Roche’s new boss open to new acquisitions
The CHF1.2 billion investment in the new research centre is a clear commitment to Basel and Switzerland, says Erismann. “Here we find the research framework that we need for our success,” he said.
Swiss Economics Minister Guy Parmelin also attended the inauguration ceremony on Tuesday.
According to Erismann, the construction of the research centre with flexible laboratories was carried out on time and within budget, despite interruptions during the Covid-19 pandemic. The new buildings are cooled with groundwater and partly heated with waste heat.
Roche has been redesigning its campus in the Kleinbasel district over the past 15 years, investing a total of CHF3.6 billion in the process, in addition to CHF1 billion in nearby Kaiseraugst, canton Aargau.
Further construction work is planned in Basel, including a third tower block. The laboratory buildings along the banks of the Rhine will also be demolished, as well as a high-rise building from the 1950s.
Adapted from German by DeepL/sb
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, if you want to learn more about how we use technology, click here, and if you have feedback on this news story please write to english@swissinfo.ch.
In compliance with the JTI standards
More: SWI swissinfo.ch certified by the Journalism Trust Initiative
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.